Human-level
cancer science.
For dogs.
An advanced blood test that reads the molecular signals associated with cancer.
DEVELOPED AT
A diagnosis can change the future you were planning for.
What happens next matters most.
The first test is the one everything else is measured against.
A blood sample taken soon after diagnosis establishes a molecular baseline: the starting point for that individual dog.
Every later sample is read against it, so change during treatment can be followed as change, not guesswork.
Is the treatment working? The answer usually arrives late.
Between scans and appointments, there is often little to go on. Routine blood tests were never designed to read the molecular patterns associated with cancer.
FOR DOGS ALREADY DIAGNOSED
CanosOncoTrack
Repeated measurements read as a trajectory, so molecular change can be followed through treatment and remission alongside the wider clinical picture.
01
Establish the baseline
One sample soon after diagnosis, before or at the start of treatment.
02
Follow the response
Further samples during treatment, read against that starting point.
03
Watch for change
Continued measurement through remission, so a shift can be seen as it happens.
One free baseline test for a recently diagnosed dog.
If your dog has recently been diagnosed with cancer, we will run the first test at no cost to establish their baseline. Whether you order any later tests is entirely up to you.
THE SCIENCE
One 5 mL sample. Many molecular signals, read together.
Fragment length, epigenetic pattern and concentration are combined into a single read, then compared against reference ranges for that individual dog.
CANOS LABORATORY · OXFORD
CO-FOUNDER
Dr Ming-Shan Tsai
Oxford DPhil in Zoology, with expertise spanning epigenetics, the genetic epidemiology of animal disease and biotechnology.
CO-FOUNDER
Dr Bin Li
PhD in Biomedical Engineering and former University of Oxford postdoctoral researcher in AI precision medicine, cancer imaging, pathology and spatial biology.
DEVELOPED AT